Production statements in monographs for mesilate‐containing drug substances and medicinal products

The British Pharmacopoeia Commission is seeking views from stakeholders on the value of continuing to include the following production statement in monographs for drug substances and formulated preparations containing mesilates.

Please follow this link to read more.

Please send your comments to bpcom@mhra.gov.uk with “Mesilate production statement comments” in the subject line by 30 September 2022.